Prescott Group Capital Management L.L.C. Raises Position in Humana Inc. (NYSE:HUM)

Prescott Group Capital Management L.L.C. lifted its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 100.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,464 shares of the insurance provider's stock after purchasing an additional 5,732 shares during the quarter. Prescott Group Capital Management L.L.C.'s holdings in Humana were worth $2,909,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HUM. BBR Partners LLC bought a new stake in Humana in the 4th quarter worth approximately $5,393,000. Callan Family Office LLC bought a new stake in Humana during the 4th quarter valued at $214,000. E Fund Management Co. Ltd. raised its stake in shares of Humana by 94.1% during the 4th quarter. E Fund Management Co. Ltd. now owns 1,450 shares of the insurance provider's stock worth $368,000 after acquiring an additional 703 shares in the last quarter. Candriam S.C.A. boosted its holdings in Humana by 178.4% in the fourth quarter. Candriam S.C.A. now owns 24,710 shares of the insurance provider's stock worth $6,269,000 after acquiring an additional 15,833 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Humana during the fourth quarter worth $26,720,000. Institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on HUM shares. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. JPMorgan Chase & Co. lowered their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Barclays raised their target price on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a report on Thursday, February 13th. Finally, Piper Sandler increased their price objective on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Twenty analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $285.68.

Remove Ads

Humana Stock Down 0.4 %

HUM traded down $1.04 on Tuesday, hitting $250.21. 1,387,813 shares of the company were exchanged, compared to its average volume of 1,676,635. The stock's fifty day moving average is $271.74 and its 200-day moving average is $282.37. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $30.19 billion, a PE ratio of 25.15, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.41%. Humana's dividend payout ratio is currently 35.58%.

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.32% of the company's stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.